QNCX•benzinga•
D. Boral Capital Maintains Buy on Quince Therapeutics, Lowers Price Target to $4
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 25, 2025 by benzinga